Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anrikefon Injection for Postoperative Pain in Laparoscopic Radical Distal Gastrectomy
NCT07330063Phase 2Recruiting
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Start
- Apr 2026
- Primary completion
- Dec 2026
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hsk21542 in postoperative pain, sponsored by Tianjin Medical University Cancer Institute and Hospital. Started Apr 2026; status: recruiting.
02
Drugs
hsk21542
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07330063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07330063.